Skip to main content

Zyprexa Relprevv

Pronunciation: zy-PREX-a REL-prev
Generic name: olanzapine (as olanzapine pamoate monohydrate)
Dosage form: extended-release injectable suspension (long-acting intramuscular injection)
Drug class: Atypical antipsychotics

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on Oct 5, 2026.

What is Zyprexa Relprevv?

Zyprexa Relprevv is a long-acting intramuscular injection containing the atypical antipsychotic olanzapine that is used to treat schizophrenia in adults. It is given by a healthcare provider as a deep injection into the buttock muscle every 2 to 4 weeks, and slowly releases olanzapine. Because of this, it is a maintenance treatment taken on a regular schedule, not a one-off injection for sudden agitation.

The exact way olanzapine works is not fully understood, but its effect in schizophrenia is thought to come from blocking two brain chemical receptors, dopamine and serotonin (5-HT2).

Olanzapine was first approved by the FDA in 1996. The long-acting Zyprexa Relprevv injection has been available in the U.S. since December, 2009 and is supplied only through a restricted program called the Zyprexa Relprevv REMS.

Zyprexa Relprevv is not approved for treating psychosis related to dementia in older adults.

Warnings

Zyprexa Relprevv has a Boxed Warning, the FDA's most serious warning, for two risks: Post-injection delirium/sedation syndrome (PDSS) and increased risk of death in older adults with dementia-related psychosis.

Post-injection delirium/sedation syndrome (PDSS)

After each injection, some of the medicine can enter the bloodstream too quickly and cause symptoms that look like an olanzapine overdose, including severe drowsiness (up to and including coma) and delirium (confusion, disorientation, agitation, trouble speaking or walking). Because of this risk:

Increased risk of death in older adults with dementia-related psychosis

Older adults with dementia-related psychosis who are treated with antipsychotic medicines have a higher risk of death and of stroke or "mini-stroke" (transient ischemic attack). Zyprexa Relprevv is not approved for this use.

Because of the PDSS risk, Zyprexa Relprevv is available only through the Zyprexa Relprevv REMS program. The prescriber, the pharmacy, the healthcare setting, and the patient must all be enrolled before treatment can be given. To enroll or for more information, call 1-877-772-9390.

Zyprexa Relprevv side effects

Common side effects

The most common side effects of Zyprexa Relprevv include:

Serious side effects

Zyprexa Relprevv may cause serious side effects. Tell your doctor or get medical help right away if you have any of the following:

It is not known if Zyprexa Relprevv is safe and effective in children under 18 years of age.

Tell your doctor about any side effect that bothers you or that does not go away. These are not all the possible side effects of Zyprexa Relprevv. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before receiving Zyprexa Relprevv

You should not receive Zyprexa Relprevv if you are allergic to olanzapine.

Before starting Zyprexa Relprevv, tell your doctor about all of your medical conditions, including if you have or have had:

Tell your doctor if you exercise a lot or are often in hot places, and tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Do not start or stop any medicine while receiving Zyprexa Relprevv without talking to your doctor first.

The symptoms of schizophrenia may include thoughts of suicide or of hurting yourself or others. If you have these thoughts at any time, tell your doctor or go to an emergency room right away.

Pregnancy

Tell your doctor if you are pregnant or plan to become pregnant. Babies exposed to antipsychotic medicines during the third trimester of pregnancy can have muscle stiffness or shakiness, tremor, sleepiness, breathing problems, feeding problems, or withdrawal symptoms after birth. If you become pregnant during treatment, tell your doctor and ask about the National Pregnancy Registry for Atypical Antipsychotics (1-866-961-2388).

Breastfeeding

Olanzapine passes into breast milk. Babies who are breastfed during treatment should be watched for excess sleepiness, irritability, poor feeding, and tremors or abnormal muscle movements. Talk to your doctor about the best way to feed your baby if you receive Zyprexa Relprevv.

Zyprexa Relprevv may affect fertility in females of reproductive potential by raising prolactin levels; this effect is reversible.

How is Zyprexa Relprevv given?

Your doctor will decide how long you need treatment. Do not stop treatment without talking to your doctor.

What happens if I miss a dose?

Because Zyprexa Relprevv is given by a healthcare provider every 2 to 4 weeks, missed doses are unlikely. If you miss a scheduled appointment, call your clinic right away to reschedule. Do not wait until your next planned appointment.

What happens if I overdose?

Zyprexa Relprevv is given by a healthcare professional in a certified setting, so an accidental overdose is unlikely. However, post-injection delirium/sedation syndrome can cause symptoms similar to an overdose, which is why you are watched for at least 3 hours after each injection. There is no specific antidote to olanzapine; treatment is supportive.

What should I avoid while receiving Zyprexa Relprevv?

What other drugs will affect Zyprexa Relprevv?

Tell your doctor about all the medicines you take. Some interactions include:

Other prescription and over-the-counter medicines, vitamins, and herbal products may also interact. Tell your doctor about any medicine you start or stop.

Does Zyprexa Relprevv interact with my other drugs?

Ingredients

Active ingredient: olanzapine (as olanzapine pamoate monohydrate)

Inactive ingredients (diluent): carboxymethylcellulose sodium, mannitol, polysorbate 80, sodium hydroxide and/or hydrochloric acid for pH adjustment, and water for injection.

Manufacturer

Zyprexa Relprevv is distributed by H2-Pharma, LLC, Montgomery, AL, USA. Licensed by CHEPLAPHARM Registration GmbH, Lörrach, Germany, which holds the Zyprexa Relprevv REMS. For more information about Zyprexa Relprevv, call 1-866-770-9010.

Common questions about Zyprexa Relprevv

What drugs cause tardive dyskinesia?

Drugs that block dopamine receptors such as some antipsychotics, antidepressants, and antiemetics, can cause tardive dyskinesia after several weeks of use. Examples are listed below by medication class.

Continue reading

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.